Search

everythinglearnresearchcommunity

for

Search:↓

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Women with PCOS are more vulnerable to severe COVID-19 and related health issues.

Ayurvedic treatment helped a woman with PCOS become pregnant and have a healthy baby.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Some breast cancer chemotherapy can cause permanent hair loss.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.